CoChat

Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment

Open access
Viegas, Cláudia, Pereira, Daniela S. M., Fonte, Pedro · 2022 · Materials

The DOI matches its Crossref record; 167 of the 169 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Head and neck cancers rank sixth among the most common cancers today, and the survival rate has remained virtually unchanged over the past 25 years, due to late diagnosis and ineffective treatments. They have two main risk factors, tobacco and alcohol, and human papillomavirus infection is a secondary risk factor. These cancers affect areas of the body that are fundamental for the five senses. Therefore, it is necessary to treat them effectively and non-invasively as early as possible, in order to do not compromise vital functions, which is not always possible with conventional treatments (chemotherapy or radiotherapy). In this sense, nanomedicine plays a key role in the treatment and diagnosis of head and neck cancers. Nanomedicine involves using nanocarriers to deliver drugs to sites of action and reducing the necessary doses and possible side effects. The main purpose of this review is to give an overview of the applications of nanocarrier systems to the diagnosis and treatment of head and neck cancer. Herein, several types of delivery strategies, radiation enhancement, inside-out hyperthermia, and theragnostic approaches are addressed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ma15062086

Cites

167 of 168 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 4 Drug delivery systems’ strategies for anticancer therapy: passive targeting and active targeting. Adapted with permission from [76].
Figure 4 Drug delivery systems’ strategies for anticancer therapy: passive targeting and active targeting. Adapted with permission from [76].CC BY · PubMed Central
Figure 1 Anatomical structures of head and neck.
Figure 1 Anatomical structures of head and neck.CC BY · PubMed Central
Figure 2 Structures and organs of the upper aerodigestive tract.
Figure 2 Structures and organs of the upper aerodigestive tract.CC BY · PubMed Central
Figure 3 Scientific areas contributing to the use of nanotechnology to nanomedicine.
Figure 3 Scientific areas contributing to the use of nanotechnology to nanomedicine.CC BY · PubMed Central
Figure 5 Organic and inorganic nanosystems for drug delivery and diagnostic applications. Size range and different shapes of nanosystems.
Figure 5 Organic and inorganic nanosystems for drug delivery and diagnostic applications. Size range and different shapes of nanosystems.CC BY · PubMed Central
Figure 6 Alterations in tumor growth over 5 weeks of treatment in 6 distinct groups of rats to study ways to overcome tumor radioresistance by increasing absorbed radiation in clinically relevant energy dosages using cetuximab carried by gold nanoparticles. Reprinted with permission from [125].
Figure 6 Alterations in tumor growth over 5 weeks of treatment in 6 distinct groups of rats to study ways to overcome tumor radioresistance by increasing absorbed radiation in clinically relevant energy dosages using cetuximab carried by gold nanoparticles. Reprinted with permission from [125].CC BY · PubMed Central
Figure 7 Nanotechnology in local hyperthermia: The nanoparticles are accumulated inside the tumor and are capable of absorbing energy from various external heat sources, thereby potentiating the effects of hyperthermia. On the right, in comparison with the left, it is possible see the effect that the nanoparticles have on heat in the tumor site. Nanoparticles focus the energy from the external source on the tumor to induce localized thermal destruction while minimizing the adverse effects on collateral tissues. Abbreviations: NPTT: nano-photo-thermal therapy. NMH: nano-magnetic hyperthermia. NaRFA: nano-radio-frequency ablation. NUH: nano-ultrasound hyperthermia. Reprinted with permission from [141].
Figure 7 Nanotechnology in local hyperthermia: The nanoparticles are accumulated inside the tumor and are capable of absorbing energy from various external heat sources, thereby potentiating the effects of hyperthermia. On the right, in comparison with the left, it is possible see the effect that the nanoparticles have on heat in the tumor site. Nanoparticles focus the energy from the external source on the tumor to induce localized thermal destruction while minimizing the adverse effects on collateral tissues. Abbreviations: NPTT: nano-photo-thermal therapy. NMH: nano-magnetic hyperthermia. NaRFA: nano-radio-frequency ablation. NUH: nano-ultrasound hyperthermia. Reprinted with permission from [141].CC BY · PubMed Central
Figure 8 Platelet-facilitated photothermal tumor therapy (PLT-PTT): Platelets (PLTs) after isolation in the blood were mixed with gold nanorods (AuNRs), which after an electroporation process, were taken up by the PLTs. The resulting AuNR-loaded PLTs (PLT-AuNRs) reached the tumor cells using in vivo photothermal tumor therapy (PTT). Reprinted with permission from [102].
Figure 8 Platelet-facilitated photothermal tumor therapy (PLT-PTT): Platelets (PLTs) after isolation in the blood were mixed with gold nanorods (AuNRs), which after an electroporation process, were taken up by the PLTs. The resulting AuNR-loaded PLTs (PLT-AuNRs) reached the tumor cells using in vivo photothermal tumor therapy (PTT). Reprinted with permission from [102].CC BY · PubMed Central
Figure 9 Quadrapeutic strategy in cancer treatment: Systemic administration of gold colloids conjugated with antibodies and liposomal drugs to form nanoclusters in cancer cells; local application of a laser pulse through an endoscope to selectively generate plasmonic nanobubbles (PNBs) in cancer cells; selective amplification of radiation by the nanocluster in cancer cells. Reprinted with permission from [161].
Figure 9 Quadrapeutic strategy in cancer treatment: Systemic administration of gold colloids conjugated with antibodies and liposomal drugs to form nanoclusters in cancer cells; local application of a laser pulse through an endoscope to selectively generate plasmonic nanobubbles (PNBs) in cancer cells; selective amplification of radiation by the nanocluster in cancer cells. Reprinted with permission from [161].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 5

  1. Mooore, K.L., Dalley, A.F., and Agur, A.M.R. (2017). Moore Clinically Oriented Anatomy, Wolters Kluwer India Pvt Ltd.
  2. Caban, 2014, Nanosystems for drug delivery, OA Drug Des. Deliv., 2, 1
  3. Niemirowicz, 2012, Nanocarriers in modern drug delivery systems, Chemik, 66, 868
  4. Ruba, 2018, Radiosensitizers and radioprotectors for effective radiation therapy—A review, Asian J. Appl. Sci. Technol., 2, 77
  5. Butterworth, 2010, UKPMC Funders Group nm gold particles: Potential application for cancer therapy, Evaluation, 21, 295101

Cited by

See all 21

Metadata

Authors
Viegas, C., Pereira, D. S. M., & Fonte, P.
Affiliations
  • Centro de Ciências do Mar do Algarve (PT)
  • University of Minho (PT)
  • University of Lisbon (PT)
Corresponding author
Fonte, Pedro
Venue
Materials
Publisher
MDPI AG
Published
2022-03-11
Volume
15
Issue
6
Pages
2086
ISSN
1996-1944 (ISSN-L)
OpenAlex
W4221071836
Cited by
21
References
169
Citations by year
2026: 4 · 2025: 7 · 2024: 4 · 2023: 5 · 2022: 1
FWCI
0.38
Type
journal article
Language
en
Open access
Locations
  • Materials (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
Funders
Fundação para a Ciência e Tecnologia (UIDB/04326/2020, UIDB/04565/2020, UIDP/04565/2020, LA/P/0140/2020, 2020.08839.BD)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
Keywords
head and neck cancer, nanomedicine, nanocarriers, drug delivery, cancer diagnosis, radiation enhancement, theranostics, non-invasive treatment, human papillomavirus, tobacco and alcohol risk factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.